TickerFacts.

Zevra Therapeutics, Inc. (ZVRA): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-16, first reflected in a filing dated 2021-03-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

56.85M
As of 2025-12-31
59.34M
As of 2026-06-30
+18.1%
3-year compound annual growth
+65.8%
5-year compound annual growth
2014-12-31: 2.38M2015-12-31: 14.49M2016-12-31: 14.65M2017-12-31: 14.66M2018-12-31: 26.46M2019-12-31: 2.27M2020-12-31: 4.54M2021-12-31: 35.01M2022-12-31: 34.54M2023-12-31: 41.53M2024-12-31: 53.67M2025-12-31: 56.85M56.85M
2014-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3156.85M+5.9%2026-03-09, Balance as of period end
2024-12-3153.67M+29.2%2026-03-09, Balance as of period end
2023-12-3141.53M+20.2%2025-03-12, Balance as of period end
2022-12-3134.54M-1.3%2024-04-01, Balance as of period end
2021-12-3135.01M+671.5%2023-03-07, Balance as of period end
2020-12-314.54Mn/c2022-03-31, Balance as of period end
2019-12-312.27Mn/c2021-03-12, Balance as of period end
2018-12-3126.46M+80.5%2020-02-28, Balance as of period end
2017-12-3114.66M+0.1%2019-03-01, Balance as of period end
2016-12-3114.65M+1.1%2018-03-30, Balance as of period end
2015-12-3114.49M+508.6%2018-03-30, Balance as of period end
2014-12-312.38Mn/a2017-03-10, Balance as of period end